Earnings Snapshot: Novartis Q3 tops revenue estimates, but misses on EPS; reaffirms FY outlook
Published 1 week ago
Oct 28, 2025 at 8:42 AM
Negative
Auto
[Seeking Alpha]
Seeking Alpha (Seeking Alpha)
MORE ON NOVARTIS
* Novartis' Deal For Avidity And Its Late-Stage Muscle Disease Assets Has Caveats [https://seekingalpha.com/article/4833776-novartis-deal-for-avidity-and-its-late-stage-muscle-disease-assets-has-caveats]
* Novartis AG (NVS) M&A Call Transcript [https://seekingalpha.com/article/4833749-novartis-ag-nvs-m-and-a-call-transcript]
* Novartis' Avidity Deal: Growth Accretive, Multiple Gated By Execution [https://seekingalpha.com/article/4833719-novartis-avidity-deal-growth-accretive-multiple-gated-by-execution]
* Novartis reports mixed Q3 results; reaffirms FY25 outlook [https://seekingalpha.com/news/4509089-novartis-reports-mixed-q3-results-reaffirms-fy25-outlook]
* Novartis Q3 2025 Earnings Preview [https://seekingalpha.com/news/4508856-novartis-q3-2025-earnings-preview]